These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 15043393

  • 1. Candida biofilms: antifungal resistance and emerging therapeutic options.
    Kuhn DM, Ghannoum MA.
    Curr Opin Investig Drugs; 2004 Feb; 5(2):186-97. PubMed ID: 15043393
    [Abstract] [Full Text] [Related]

  • 2. Candida biofilm resistance.
    Mukherjee PK, Chandra J.
    Drug Resist Updat; 2004 Feb; 7(4-5):301-9. PubMed ID: 15533767
    [Abstract] [Full Text] [Related]

  • 3. Biofilm lifestyle of Candida: a mini review.
    Seneviratne CJ, Jin L, Samaranayake LP.
    Oral Dis; 2008 Oct; 14(7):582-90. PubMed ID: 19076549
    [Abstract] [Full Text] [Related]

  • 4. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
    Samaranayake YH, Cheung BP, Parahitiyawa N, Seneviratne CJ, Yau JY, Yeung KW, Samaranayake LP.
    Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
    [Abstract] [Full Text] [Related]

  • 5. Antifungal activity against Candida biofilms.
    Iñigo M, Pemán J, Del Pozo JL.
    Int J Artif Organs; 2012 Oct; 35(10):780-91. PubMed ID: 23138707
    [Abstract] [Full Text] [Related]

  • 6. Thymol inhibits Candida albicans biofilm formation and mature biofilm.
    Braga PC, Culici M, Alfieri M, Dal Sasso M.
    Int J Antimicrob Agents; 2008 May; 31(5):472-7. PubMed ID: 18329858
    [Abstract] [Full Text] [Related]

  • 7. A subpopulation of Candida albicans and Candida tropicalis biofilm cells are highly tolerant to chelating agents.
    Harrison JJ, Turner RJ, Ceri H.
    FEMS Microbiol Lett; 2007 Jul; 272(2):172-81. PubMed ID: 17490429
    [Abstract] [Full Text] [Related]

  • 8. In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.
    Cateau E, Rodier MH, Imbert C.
    J Antimicrob Chemother; 2008 Jul; 62(1):153-5. PubMed ID: 18407917
    [Abstract] [Full Text] [Related]

  • 9. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.
    Seidler M, Salvenmoser S, Müller FM.
    Int J Antimicrob Agents; 2006 Dec; 28(6):568-73. PubMed ID: 17101265
    [Abstract] [Full Text] [Related]

  • 10. The European Confederation of Medical Mycology (ECMM) survey of candidaemia in Italy: in vitro susceptibility of 375 Candida albicans isolates and biofilm production.
    Tortorano AM, Prigitano A, Biraghi E, Viviani MA, FIMUA-ECMM Candidaemia Study Group.
    J Antimicrob Chemother; 2005 Oct; 56(4):777-9. PubMed ID: 16144871
    [Abstract] [Full Text] [Related]

  • 11. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S, Moran GP, Sullivan DJ, Kucharíková S, Chorvát D, Bujdáková H.
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [Abstract] [Full Text] [Related]

  • 12. In vitro growth and analysis of Candida biofilms.
    Chandra J, Mukherjee PK, Ghannoum MA.
    Nat Protoc; 2008 Mar; 3(12):1909-24. PubMed ID: 19180075
    [Abstract] [Full Text] [Related]

  • 13. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance.
    Jabra-Rizk MA, Shirtliff M, James C, Meiller T.
    FEMS Yeast Res; 2006 Nov; 6(7):1063-73. PubMed ID: 17042756
    [Abstract] [Full Text] [Related]

  • 14. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
    Bruzual I, Riggle P, Hadley S, Kumamoto CA.
    J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
    [Abstract] [Full Text] [Related]

  • 15. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
    Ramage G, López-Ribot JL.
    Methods Mol Med; 2005 Mar; 118():71-9. PubMed ID: 15888936
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of baicalein against Candida albicans biofilms.
    Cao Y, Dai B, Wang Y, Huang S, Xu Y, Cao Y, Gao P, Zhu Z, Jiang Y.
    Int J Antimicrob Agents; 2008 Jul; 32(1):73-7. PubMed ID: 18374543
    [Abstract] [Full Text] [Related]

  • 17. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans.
    Watamoto T, Samaranayake LP, Jayatilake JA, Egusa H, Yatani H, Seneviratne CJ.
    Int J Antimicrob Agents; 2009 Oct; 34(4):333-9. PubMed ID: 19376687
    [Abstract] [Full Text] [Related]

  • 18. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M, Karaman M.
    Mikrobiyol Bul; 2004 Oct; 38(1-2):91-8. PubMed ID: 15293907
    [Abstract] [Full Text] [Related]

  • 19. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.
    Muñoz P, Sánchez-Somolinos M, Alcalá L, Rodríguez-Créixems M, Peláez T, Bouza E.
    J Antimicrob Chemother; 2005 Feb; 55(2):188-93. PubMed ID: 15650001
    [Abstract] [Full Text] [Related]

  • 20. [The yeast biofilm in human medicine].
    Růzicka F, Holá V, Votava M.
    Klin Mikrobiol Infekc Lek; 2007 Aug; 13(4):145-9. PubMed ID: 17929219
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.